{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7385,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes spider plots/swimmer-style plots for tumor response and bar charts for best percentage change.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/44",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a scatter plot to map clinical trials and a table to summarize treatment outcomes across lines of therapy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/45",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide presents clinical data for a small sample size (n=4) in a highly pre-treated patient population.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/46",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 47,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Shows two parallel tracks: monotherapy and combination therapy with tislelizumab.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/47",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-47",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 48,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/48",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-48",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 49,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a process-flow style layout to connect platform capabilities to specific product outputs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/49",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-49",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 50,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a process-to-product mapping structure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/50",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-50",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 51,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes technical diagrams of the drug delivery vehicle and comparative histology/survival data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/51",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-51",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 52,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes two sets of charts: tumor volume over time and survival curves.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/52",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-52",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 53,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes multiple citations and diagrams illustrating the mechanism of action and clinical efficacy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/53",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-53",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 54,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide uses a numbered list format to present key value propositions for the company's pipeline.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/54",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-54",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 55,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/55",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-55",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 56,
      "slideType": "solution",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/56",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-56",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 57,
      "slideType": "other",
      "function": "plan_implementation",
      "notes": "The slide uses a serpentine process flow (1-5 left-to-right, 6-10 right-to-left).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/57",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-57",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 58,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "Highlights NXC-201's lower fludarabine dose and compares infusion timing across therapies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/58",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-58",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 59,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a combination of expert testimonials and a comparative table of clinical trials to validate the outpatient administration model.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/59",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-59",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 60,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a bar chart to contrast the combined sales of two groups of drugs, implying a large market opportunity for TSTx.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/60",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-60",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4adb-70ab-b20d-0cecfafab920",
      "docSlug": "c241ac9edd2443452257949ce0a73d65",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 61 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 61,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a bar chart comparison to highlight the efficacy gap between established treatments and placebo.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4adb-70ab-b20d-0cecfafab920/61",
      "deckHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920",
      "deckAnchorHref": "/decks/019de076-4adb-70ab-b20d-0cecfafab920#slide-61",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 61,
          "from": 18,
          "beatId": "9e3b7806-5df2-416a-a768-acc5827c37ab",
          "arcName": "AIDA",
          "arcSlug": "aida",
          "beatName": "Action",
          "beatSlug": "aida-action",
          "evidence": "The deck concludes with a call to action, roadmap, and investment highlights",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4b6e-745e-b621-2097373bdc12",
      "docSlug": "454a033dcd11e0912fc4b281c3c86d65",
      "documentTitle": "Innoviva | Results Presentation Deck | 7 slides",
      "authorId": "innoviva",
      "authorName": "Innoviva",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/uUdjvyugSDhr8D8NWjUoZQt3-umPXk41oM1lOTUxzkI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80NTRhMDMzZGNkMTFlMDkxMmZjNGIyODFjM2M4NmQ2NS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4b6e-745e-b621-2097373bdc12/1",
      "deckHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12",
      "deckAnchorHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 1,
          "from": 1,
          "beatId": "57d1ba59-1c03-46ee-94cf-a1df2cf56e8b",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Attention",
          "beatSlug": "monroes-sequence-attention",
          "evidence": "Topline data announcement",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Hook",
          "parentBeatSlug": "hook"
        }
      ],
      "imagePathAlt": "https://imgproxy.kitesheet.com/0y12cSMcrksLIN9Lilb0X11O-9fnhrgJeAC61MFp-1c/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80NTRhMDMzZGNkMTFlMDkxMmZjNGIyODFjM2M4NmQ2NS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/xPMDlb79IZpnJ5E1SdvNyJqD3IfW8fApvcSSUmo7E5g/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80NTRhMDMzZGNkMTFlMDkxMmZjNGIyODFjM2M4NmQ2NS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/W7Dsu6h4A7rHMV5kLcUzd_hKAOIeXEcGNkK_rKJzlRU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80NTRhMDMzZGNkMTFlMDkxMmZjNGIyODFjM2M4NmQ2NS9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-4b6e-745e-b621-2097373bdc12",
      "docSlug": "454a033dcd11e0912fc4b281c3c86d65",
      "documentTitle": "Innoviva | Results Presentation Deck | 7 slides",
      "authorId": "innoviva",
      "authorName": "Innoviva",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "Headline doubles as action title with a positive-result takeaway; body is a pure bulleted summary with footnoted Lancet citations and Innoviva branding bottom-right.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4b6e-745e-b621-2097373bdc12/2",
      "deckHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12",
      "deckAnchorHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12#slide-2",
      "loopMatches": [
        {
          "to": 7,
          "from": 2,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "cc60ccb3-7bfb-482b-bd2f-71df33588aa9",
          "evidence": "Implication of antibiotic resistance and need for new treatments",
          "position": 0,
          "objective": "What are the consequences of not adopting Zoliflodacin?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 2,
          "from": 2,
          "beatId": "2dd973bd-2205-4a64-8b7e-91aa8f1ca8cd",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "Positive topline summary",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4b6e-745e-b621-2097373bdc12",
      "docSlug": "454a033dcd11e0912fc4b281c3c86d65",
      "documentTitle": "Innoviva | Results Presentation Deck | 7 slides",
      "authorId": "innoviva",
      "authorName": "Innoviva",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "The diagram illustrates a randomized controlled trial structure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4b6e-745e-b621-2097373bdc12/3",
      "deckHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12",
      "deckAnchorHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12#slide-3",
      "loopMatches": [
        {
          "to": 7,
          "from": 2,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "cc60ccb3-7bfb-482b-bd2f-71df33588aa9",
          "evidence": "Implication of antibiotic resistance and need for new treatments",
          "position": 0,
          "objective": "What are the consequences of not adopting Zoliflodacin?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4b6e-745e-b621-2097373bdc12",
      "docSlug": "454a033dcd11e0912fc4b281c3c86d65",
      "documentTitle": "Innoviva | Results Presentation Deck | 7 slides",
      "authorId": "innoviva",
      "authorName": "Innoviva",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "appendix_methodology",
      "function": "analyze_data",
      "notes": "Flowchart shows patient progression from screening to dosing and categorization by infection site.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4b6e-745e-b621-2097373bdc12/4",
      "deckHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12",
      "deckAnchorHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12#slide-4",
      "loopMatches": [
        {
          "to": 7,
          "from": 2,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "cc60ccb3-7bfb-482b-bd2f-71df33588aa9",
          "evidence": "Implication of antibiotic resistance and need for new treatments",
          "position": 0,
          "objective": "What are the consequences of not adopting Zoliflodacin?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4b6e-745e-b621-2097373bdc12",
      "docSlug": "454a033dcd11e0912fc4b281c3c86d65",
      "documentTitle": "Innoviva | Results Presentation Deck | 7 slides",
      "authorId": "innoviva",
      "authorName": "Innoviva",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "key_takeaways",
      "function": "analyze_data",
      "notes": "Clinical trial results presentation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4b6e-745e-b621-2097373bdc12/5",
      "deckHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12",
      "deckAnchorHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12#slide-5",
      "loopMatches": [
        {
          "to": 7,
          "from": 2,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "cc60ccb3-7bfb-482b-bd2f-71df33588aa9",
          "evidence": "Implication of antibiotic resistance and need for new treatments",
          "position": 0,
          "objective": "What are the consequences of not adopting Zoliflodacin?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 5,
          "beatId": "6a75d401-e4e0-4675-b9e7-0be4bf3b7d11",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "Primary endpoint achieved, secondary analyses show comparable results",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4b6e-745e-b621-2097373bdc12",
      "docSlug": "454a033dcd11e0912fc4b281c3c86d65",
      "documentTitle": "Innoviva | Results Presentation Deck | 7 slides",
      "authorId": "innoviva",
      "authorName": "Innoviva",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "comparison_table",
      "function": "analyze_data",
      "notes": "The slide highlights that these secondary analyses were not powered for statistical significance.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4b6e-745e-b621-2097373bdc12/6",
      "deckHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12",
      "deckAnchorHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12#slide-6",
      "loopMatches": [
        {
          "to": 7,
          "from": 2,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "cc60ccb3-7bfb-482b-bd2f-71df33588aa9",
          "evidence": "Implication of antibiotic resistance and need for new treatments",
          "position": 0,
          "objective": "What are the consequences of not adopting Zoliflodacin?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 5,
          "beatId": "6a75d401-e4e0-4675-b9e7-0be4bf3b7d11",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "Primary endpoint achieved, secondary analyses show comparable results",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4b6e-745e-b621-2097373bdc12",
      "docSlug": "454a033dcd11e0912fc4b281c3c86d65",
      "documentTitle": "Innoviva | Results Presentation Deck | 7 slides",
      "authorId": "innoviva",
      "authorName": "Innoviva",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses a split-layout with key takeaways on the left and supporting clinical data tables on the right.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4b6e-745e-b621-2097373bdc12/7",
      "deckHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12",
      "deckAnchorHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12#slide-7",
      "loopMatches": [
        {
          "to": 7,
          "from": 2,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "cc60ccb3-7bfb-482b-bd2f-71df33588aa9",
          "evidence": "Implication of antibiotic resistance and need for new treatments",
          "position": 0,
          "objective": "What are the consequences of not adopting Zoliflodacin?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 7,
          "from": 7,
          "beatId": "ed7992a7-59f2-4e41-9ca1-562e5b4b2bc7",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "Favorable safety and tolerability profile",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4c3e-73ae-87d7-d7187ae96427",
      "docSlug": "ecbbf8a27cd0b92fd1fdafe442098019",
      "documentTitle": "Innoviz | Results Presentation Deck | 20 slides",
      "authorId": "innoviz",
      "authorName": "Innoviz Technologies",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/NR27DB4hX2-DnmiZwQz-CKnAKLGDnDxWMolEb1R0Jqk/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lY2JiZjhhMjdjZDBiOTJmZDFmZGFmZTQ0MjA5ODAxOS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4c3e-73ae-87d7-d7187ae96427/1",
      "deckHref": "/decks/019de076-4c3e-73ae-87d7-d7187ae96427",
      "deckAnchorHref": "/decks/019de076-4c3e-73ae-87d7-d7187ae96427#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 1,
          "beatId": "5b4435c2-1715-4bcd-9434-09200ef43e5b",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Setup",
          "beatSlug": "setup",
          "evidence": "The presentation begins with a cover slide, disclaimer, thesis headline, and agenda, setting the stage for the presentation.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": "https://imgproxy.kitesheet.com/Ec5uX_RB_fS15GVVCN167vl6ZNgU33nwZ9VNUTgwxjU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lY2JiZjhhMjdjZDBiOTJmZDFmZGFmZTQ0MjA5ODAxOS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/fe88DGEUUtsw2S05rkzJVInVtIEhjDf5HwQg0GT6-vw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lY2JiZjhhMjdjZDBiOTJmZDFmZGFmZTQ0MjA5ODAxOS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/9QIFD_OkQPZhnwTTfGugrzv1JZ1LfBDv29ZHYZgbTwE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lY2JiZjhhMjdjZDBiOTJmZDFmZGFmZTQ0MjA5ODAxOS9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-4c3e-73ae-87d7-d7187ae96427",
      "docSlug": "ecbbf8a27cd0b92fd1fdafe442098019",
      "documentTitle": "Innoviz | Results Presentation Deck | 20 slides",
      "authorId": "innoviz",
      "authorName": "Innoviz Technologies",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4c3e-73ae-87d7-d7187ae96427/2",
      "deckHref": "/decks/019de076-4c3e-73ae-87d7-d7187ae96427",
      "deckAnchorHref": "/decks/019de076-4c3e-73ae-87d7-d7187ae96427#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 1,
          "beatId": "5b4435c2-1715-4bcd-9434-09200ef43e5b",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Setup",
          "beatSlug": "setup",
          "evidence": "The presentation begins with a cover slide, disclaimer, thesis headline, and agenda, setting the stage for the presentation.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4c3e-73ae-87d7-d7187ae96427",
      "docSlug": "ecbbf8a27cd0b92fd1fdafe442098019",
      "documentTitle": "Innoviz | Results Presentation Deck | 20 slides",
      "authorId": "innoviz",
      "authorName": "Innoviz Technologies",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "thesis_headline",
      "function": "establish_context",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4c3e-73ae-87d7-d7187ae96427/3",
      "deckHref": "/decks/019de076-4c3e-73ae-87d7-d7187ae96427",
      "deckAnchorHref": "/decks/019de076-4c3e-73ae-87d7-d7187ae96427#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 1,
          "beatId": "5b4435c2-1715-4bcd-9434-09200ef43e5b",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Setup",
          "beatSlug": "setup",
          "evidence": "The presentation begins with a cover slide, disclaimer, thesis headline, and agenda, setting the stage for the presentation.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4c3e-73ae-87d7-d7187ae96427",
      "docSlug": "ecbbf8a27cd0b92fd1fdafe442098019",
      "documentTitle": "Innoviz | Results Presentation Deck | 20 slides",
      "authorId": "innoviz",
      "authorName": "Innoviz Technologies",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "agenda",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4c3e-73ae-87d7-d7187ae96427/4",
      "deckHref": "/decks/019de076-4c3e-73ae-87d7-d7187ae96427",
      "deckAnchorHref": "/decks/019de076-4c3e-73ae-87d7-d7187ae96427#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 1,
          "beatId": "5b4435c2-1715-4bcd-9434-09200ef43e5b",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Setup",
          "beatSlug": "setup",
          "evidence": "The presentation begins with a cover slide, disclaimer, thesis headline, and agenda, setting the stage for the presentation.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-4c3e-73ae-87d7-d7187ae96427",
      "docSlug": "ecbbf8a27cd0b92fd1fdafe442098019",
      "documentTitle": "Innoviz | Results Presentation Deck | 20 slides",
      "authorId": "innoviz",
      "authorName": "Innoviz Technologies",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "The slide uses a split layout with a dark sidebar for branding and a large photo of the vehicle on the right.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-4c3e-73ae-87d7-d7187ae96427/5",
      "deckHref": "/decks/019de076-4c3e-73ae-87d7-d7187ae96427",
      "deckAnchorHref": "/decks/019de076-4c3e-73ae-87d7-d7187ae96427#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 5,
          "beatId": "078df2ee-0aa4-4932-a5e9-4608306cb102",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Key Takeaways",
          "beatSlug": null,
          "evidence": "The key takeaways slide highlights important information about the company's performance.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}